We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Two influential House lawmakers are seeking documents from the FDA to help shed light on whether the agency knew about problems at vaccine maker Chiron's manufacturing facility in England, which was forced to suspend production of the Fluvirin flu vaccine by UK health regulators.
The FDA has issued a warning letter to California-based drug repackaging firm PharmPak, after discovering that deficiencies in the firm’s repackaging process may have resulted in cross-contamination between penicillin and nonpenicillin products.